Kavar Capital Partners Group’s Edwards Lifesciences EW Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-9,497	Closed	-$703K	–	184
2024 Q4	$703K	Sell	9,497 -1,380	-13%	-$96.6K	0.12%	105
2024 Q3	$718K	Sell	10,877 -1,417	-12%	-$103K	0.11%	108
2024 Q2	$1.14M	Sell	12,294 -1,090	-8%	-$96.5K	0.2%	88
2024 Q1	$1.28M	Sell	13,384 -14,764	-52%	-$1.24M	0.24%	82
2023 Q4	$2.15M	Buy	28,148 +7,309	+35%	+$509K	0.24%	81
2023 Q3	$1.44M	Sell	20,839 -1,245	-6%	-$100K	0.31%	75
2023 Q2	$2.08M	Sell	22,084 -527	-2%	-$45.8K	0.44%	64
2023 Q1	$1.87M	Sell	22,611 -470	-2%	-$36.9K	0.4%	66
2022 Q4	$1.72M	Sell	23,081 -4,270	-16%	-$329K	0.4%	67
2022 Q3	$2.26M	Buy	27,351 +209	+0.8%	+$20.1K	0.58%	52
2022 Q2	$2.58M	Buy	27,142 +1,163	+4%	+$120K	0.6%	50
2022 Q1	$3.06M	Buy	25,979 +143	+0.6%	+$16K	0.66%	44
2021 Q4	$3.35M	Buy	25,836 +481	+2%	+$56.1K	0.7%	44
2021 Q3	$2.87M	Buy	25,355 +235	+0.9%	+$26.8K	0.65%	46
2021 Q2	$2.6M	Buy	25,120 +715	+3%	+$67.4K	0.63%	48
2021 Q1	$2.04M	Buy	24,405 +145	+0.6%	+$12.3K	0.55%	60
2020 Q4	$2.21M	Buy	24,260 +15,870	+189%	+$1.32M	0.64%	49
2020 Q3	$670K	Buy	8,390 +705	+9%	+$55K	0.23%	84
2020 Q2	$531K	Buy	+7,685	New	+$546K	0.2%	85